Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

Dow University of Health Sciences · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
antibody
covid19, covid19 (corona virus disease-2019), sars-cov-2 (severe acute respiratory syndrome coronavirus 2), passive immunization, intravenous immunoglobulin (ivig), pooled convalescent plasma, severe ill covid-19 patients, antibody, anti covid 19 antibodies, anti sars cov 2 antibodies, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 967034
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.